Market analyst Mitesh Thakkar has suggested four BUY calls and no SELL call for today’s trading session. Investors are concerned about second wave of COVID-19 and the delay in vaccine development for the virus. Pharmaceutical major AstraZeneca has finalized a deal with Inclusive Vaccines Alliance in Europe to supply up to 400 million doses of an experimental COVID-19 vaccine. The management expects to launch vaccine by the end of 2020.

Thakkar suggests traders to initiate a BUY trade in commercial automobile major Ashok Leyland with a stop loss of Rs 50, target at Rs 56. Other stock on Thakkar’s buy list for the session is small private bank RBL Bank. Traders can BUY RBL Bank with a stop loss of Rs 160, target at Rs 185.

Thakkar has also suggested BUY Call for Cadila Healthcare. Technical analyst Sudarshan Sukhani has also suggested BUY call for Cadila Healthcare for today’s session. Traders can Buy Cadila Health with a stop loss of Rs 368, target at Rs 388, as per Thakkar.

Traders can also Buy MRF with a stop loss of Rs 63,000, target at Rs 66,000 as per Thakkar. MRF stock has firmed up in the recent trading sessions. We could see further momentum in the stock.

Indian markets are expected to trade in a narrow range for today’s trading session and we could see a positive closing.